Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
Lorenzo Castagnoli(Fondazione IRCCS Istituto Nazionale dei Tumori), Serenella M. Pupa(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 21
Related Papers
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
|Oncogene|2019|185
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
|Journal of Experimental & Clinical Cancer Research|2025|11